These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10408368)

  • 1. Molecular remodeling of complement regulatory proteins for xenotransplantation.
    Seya T; Mikata S; Fukui A; Murakami Y; Matsumoto M; Nagasawa S
    Immunopharmacology; 1999 May; 42(1-3):75-80. PubMed ID: 10408368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperacute xenograft rejection in the swine-to-human donor-recipient combination. In vitro analysis of complement activation.
    Zhao Z; Termignon JL; Cardoso J; Chéreau C; Gautreau C; Calmus Y; Houssin D; Weill B
    Transplantation; 1994 Jan; 57(2):245-9. PubMed ID: 8310516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolongation of cardiac xenograft survival by depletion of complement.
    Leventhal JR; Dalmasso AP; Cromwell JW; Platt JL; Manivel CJ; Bolman RM; Matas AJ
    Transplantation; 1993 Apr; 55(4):857-65; discussion 865-6. PubMed ID: 8475561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xenotransplantation.
    Cozzi E; White DJ
    Curr Opin Nephrol Hypertens; 1996 Nov; 5(6):514-8. PubMed ID: 8978999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement activation in discordant hepatic xenotransplantation.
    Tector AJ; Chen X; Soderland C; Tchervenkov JI
    Xenotransplantation; 1998 Nov; 5(4):257-61. PubMed ID: 9915253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of complement in xenotransplantation.
    Mollnes TE; Fiane AE
    Allergy; 2002; 57 Suppl 72():75-8. PubMed ID: 12144560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complement in organ xenotransplantation].
    Dalmasso AP
    Rev Clin Esp; 1996 Mar; 196 Spec No():44-51. PubMed ID: 9206808
    [No Abstract]   [Full Text] [Related]  

  • 8. The immunological hurdles to cardiac xenotransplantation.
    Platt JL
    J Card Surg; 2001; 16(6):439-47. PubMed ID: 11925024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for complement in the rejection of porcine ventral mesencephalic xenografts in a rat model of Parkinson's disease.
    Barker RA; Ratcliffe E; McLaughlin M; Richards A; Dunnett SB
    J Neurosci; 2000 May; 20(9):3415-24. PubMed ID: 10777804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular remodelling of human CD46 for xenotransplantation: designing a potent complement regulator without measles virus receptor activity.
    Begum NA; Murakami Y; Mikata S; Matsumoto M; Hatanaka M; Nagasawa S; Kinoshita T; Seya T
    Immunology; 2000 May; 100(1):131-9. PubMed ID: 10809968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A synthetic dextran derivative inhibits complement activation and complement-mediated cytotoxicity in an in vitro model of hyperacute xenograft rejection.
    Thomas H; Maillet F; Letourneur D; Jozefonvicz J; Kazatchkine MD; Fischer E
    Transplant Proc; 1996 Apr; 28(2):593-4. PubMed ID: 8623290
    [No Abstract]   [Full Text] [Related]  

  • 12. Attempts to prepare suitable complement regulatory molecules for clinical xenotransplantation.
    Miyagawa S; Matsunami K; Yoshitatsu M; Mikata S; Matsuda H; Shirakura R
    J Card Surg; 2001; 16(6):429-38. PubMed ID: 11925023
    [No Abstract]   [Full Text] [Related]  

  • 13. Complement activation, its consequences, and blockade by gene transfer.
    Carrington CA; Richards AC; van den Bogaerde J; Tucker AW; White DJ
    World J Surg; 1997; 21(9):907-12. PubMed ID: 9361503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human DAF on pig cells protects against human and non-human primate sera cytotoxicity mediated by exogenous or endogenous complement, as determined by flow cytometry.
    Díaz-Román TM; Mañez R; López-Pelaez E; Centeno A; Moscoso I; Pértegaz S; Doménech N
    Transpl Immunol; 2006 Aug; 16(2):125-30. PubMed ID: 16860716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Xenotransplantation: physiopathology of hyperacute and differentiated rejection, and therapeutic perspectives].
    Malassagne B; Calmus Y; Houssin D; Weill B
    Pathol Biol (Paris); 2000 May; 48(4):377-82. PubMed ID: 10868402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of soluble complement receptor type 1 on acute humoral xenograft rejection in hDAF-transgenic pig-to-primate life-supporting kidney xenografts.
    Lam TT; Hausen B; Hook L; Lau M; Higgins J; Christians U; Jacobsen W; Baluom M; Duthaler R; Katopodis A; Chavez G; Cozzi E; Harrison R; Schuurman HJ; Borie D; Morris RE
    Xenotransplantation; 2005 Jan; 12(1):20-9. PubMed ID: 15598270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of the complement system for xenotransplantation: strategies for therapeutic intervention].
    Kirschfink M; Haferkamp A; Pomer S; Chrupcala M; Wosnik A; Heckl-Ostreicher B
    Zentralbl Chir; 1998; 123(7):793-7. PubMed ID: 9746977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of hyperacute xenograft rejection in orthotopic xenotransplantation of pig hearts into baboons using immunoadsorption of antibodies and complement factors.
    Brenner P; Reichenspurner H; Schmoeckel M; Wimmer C; Rucker A; Eder V; Meiser B; Hinz M; Felbinger T; Hammer C; Reichart B
    Transpl Int; 2000; 13 Suppl 1():S508-17. PubMed ID: 11112063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of complement-mediated swine endothelial cell lysis by a surface-bound form of human C4b binding protein.
    Mikata S; Miyagawa S; Iwata K; Nagasawa S; Hatanaka M; Matsumoto M; Kamiike W; Matsuda H; Shirakura R; Seya T
    Transplantation; 1998 Feb; 65(3):363-8. PubMed ID: 9484752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordant xenografting: challenges and controversies.
    Platt JL; Bach FH
    Curr Opin Immunol; 1991 Oct; 3(5):735-9. PubMed ID: 1755990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.